Topic 5.2
Tomorrow.bio advantage
A brief history of Tomorrow.bioTomorrow.bio was founded in 2020 and built a European cryopreservation operation, a Swiss storage facility and a three-organisation patient-care structure before expanding to the continental United States.Why Tomorrow.bio’s preservation quality is unmatchedTomorrow.bio combines whole-body field cryoprotection, detailed case data, controlled cooldown, standardized cryogenic CT for every patient, public reports and developing ultrastructural analysis. We believe this is the most complete and measurable human cryopreservation programme in the world.The foundersEmil Kendziorra and Fernando Azevedo Pinheiro brought complementary medical, scientific, engineering and operational experience to Tomorrow.bio. Their real legacy is the institution they are building to outlast them.The vision of Tomorrow.bio membershipTomorrow.bio membership is designed as a lifelong relationship: preservation readiness, practical lifespan support, member connections, and continued investment in better cryopreservation.Lifespan extension’s backup planTomorrow.bio's Lifespan Extension Program gives members expert longevity support while cryopreservation remains ready as a backup and revival research moves forward.Applied engineeringApplied engineering at Tomorrow.bio starts with constraints and failures from real cases, then turns them into better mobile equipment, monitoring and procedures for the next patient.What actually happens when you need us?When a member enters a critical condition, early notification lets Tomorrow.bio coordinate standby, the medical procedure, paperwork, transport, quality review and transfer into long-term care.Research and development initiativesTomorrow.bio improves today’s cryopreservation procedures while testing the harder technologies needed for future revival, with deployed systems, active trials and long-term goals clearly separated.